Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
Lloyd Sanders Epic Sciences Clinical Experience Program Capital Partners Deerfield Management Blue Ox Healthcare Partners
Source: genomeweb.com